Carregant...
ACS Chemical Neuroscience Molecule Spotlight on BMS-708163
[Image: see text] BMS-708163 is a novel, sulfonamide containing γ-secretase inhibitor from Bristol-Myers Squibb Co. currently in Phase II clinical trials for the treatment of Alzheimer’s disease (AD).
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Chemical
Society
2012
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3369796/ https://ncbi.nlm.nih.gov/pubmed/22860183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn3000179 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|